TAVR Case Volume Identified as Predominant Factor Behind EPD Use

The use of an embolic protection device (EPD) during TAVR remains infrequent, and the most common factor related to EPD use is TAVR case volume, not TAVR reimbursement by the Centers for Medicare and Medicaid Services (CMS) or its new technology add-on payment, according to a study published in JAMA Cardiology.

Iron Deficiency and Treatment For Cardiovascular Disease

Iron deficiency (ID) is common among patients with a broad range of cardiovascular disease and future research is needed to understand the types of patients who are more likely to benefit from iron supplementation, according to a state-of-the-art review by Gianluigi Savarese, MD, and Stephan von Haehling, MD, et al., published in the European Heart Journal.